PROM1 and glioblastoma: Our work also aims to (i) establish in vivo assays to evaluate the tumorigenicity of CD133+ cells in conjunction to with the migration of MSCs toward GBM, (ii) assess MSCs contribution to tumor development, invasion and metastatic dissemination, and (iii) the role of exosomes release by MSCs in these processes.